145 related articles for article (PubMed ID: 6805422)
1. In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
Piot P; Van Dyck E
Antimicrob Agents Chemother; 1982 Jan; 21(1):166-7. PubMed ID: 6805422
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Liljequist BO; Gezelius L
Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
[TBL] [Abstract][Full Text] [Related]
3. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
Wise R; Andrews JM; Bedford KA
J Antimicrob Chemother; 1980 Mar; 6(2):197-206. PubMed ID: 6247316
[No Abstract] [Full Text] [Related]
4. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
Doern GV; Tubert TA
Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
Doern GV; Siebers KG; Hallick LM; Morse SA
Antimicrob Agents Chemother; 1980 Jan; 17(1):24-9. PubMed ID: 6766292
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
Renkonen OV
Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
[TBL] [Abstract][Full Text] [Related]
7. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
Cooper CE; Slocombe B; White AR
J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
Fernández-Roblas R; Jiménez Arriero M; Rodriguez-Tudela JL; Soriano F
J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a true post-beta-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae.
Murbach V; Dhoyen N; Linger L; Monteil H; Jehl F
Clin Microbiol Infect; 2001 Dec; 7(12):661-5. PubMed ID: 11843906
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains.
Thornsberry C; Baker CN; Jones RN
J Antimicrob Chemother; 1979 Mar; 5(2):137-42. PubMed ID: 107152
[No Abstract] [Full Text] [Related]
13. In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics.
Ng WS; Chau PY; Arnold K
Antimicrob Agents Chemother; 1981 May; 19(5):925-6. PubMed ID: 6271052
[TBL] [Abstract][Full Text] [Related]
14. [Serotype distribution and drug resistance of
Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
[No Abstract] [Full Text] [Related]
15. Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.
Doern GV; Jones RN
Antimicrob Agents Chemother; 1988 Dec; 32(12):1747-53. PubMed ID: 3149883
[No Abstract] [Full Text] [Related]
16. Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains.
Fuchs PC; Barry AL; Jones RN; Thornsberry C
Diagn Microbiol Infect Dis; 1984 Jan; 2(1):55-63. PubMed ID: 6443203
[TBL] [Abstract][Full Text] [Related]
17. The influence of clavulanic acid on the susceptibility to amoxycillin of beta-lactamase producing strains of H. influenzae using different inoculum sizes.
Van Klingeren B; Dessens-Kroon M
J Antimicrob Chemother; 1979 May; 5(3):322-3. PubMed ID: 314442
[No Abstract] [Full Text] [Related]
18. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.
Miller JM; Baker CN; Thornsberry C
Antimicrob Agents Chemother; 1978 Nov; 14(5):794-6. PubMed ID: 103496
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the inoculum effect with Haemophilus influenzae and beta-lactams.
Balko T; Karlowsky JA; Palatnick LP; Zhanel GG; Hoban DJ
Diagn Microbiol Infect Dis; 1999 Jan; 33(1):47-58. PubMed ID: 9990476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
